The impact of diabetes mellitus on blood-tissue barrier regulation and vascular complications: Is the lung different from other organs?

Abdulaziz H Alanazi,Mohamed S Selim,Manyasreeprapti R Yendamuri,Duo Zhang,S Priya Narayanan,Payaningal R Somanath,Abdulaziz H. Alanazi Mohamed S. Selim Manyasreeprapti R. Yendamuri Duo Zhang S. Priya Narayanan Payaningal R. Somanath a Clinical and Experimental Therapeutics,University of Georgia,Augusta,GA,USAb Charlie Norwood VA Medical Center,Augusta,GA,USAc Department of Clinical Practice,College of Pharmacy,Northern Border University,Rafha,Saudi Arabia

DOI: https://doi.org/10.1080/21688370.2024.2386183

2024-07-30

Tissue Barriers

Abstract:Diabetes Mellitus presents a formidable challenge as one of the most prevalent and complex chronic diseases, exerting significant strain on both patients and the world economy. It is recognized as a common comorbidity among severely ill individuals, often leading to a myriad of micro- and macro-vascular complications. Despite extensive research dissecting the pathophysiology and molecular mechanisms underlying vascular complications of diabetes, relatively little attention has been paid to potential lung-related complications. This review aims to illuminate the impact of diabetes on prevalent respiratory diseases, including chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), tuberculosis (TB), pneumonia infections, and asthma, and compare the vascular complications with other vascular beds. Additionally, we explore the primary mechanistic pathways contributing to these complications, such as the expression modulation of blood-tissue-barrier proteins, resulting in increased paracellular and transcellular permeability, and compromised immune responses rendering diabetes patients more susceptible to infections. The activation of inflammatory pathways leading to cellular injury and hastening the onset of these respiratory complications is also discussed.